换一批
换一批The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
第一作者：
Zhilan,Zhang
第一单位：
Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
作者：
关键词
ACE2 expressionACE2, angiotensin-converting enzyme 2CESC, cervical squamous-cell carcinomaCOAD, colon adenocarcinomaDFI, disease-free intervalDSS, disease-specific survivalEMT, epithelial-mesenchymal transitionESCA, esophageal carcinomaFDR, false discovery rateGO, gene ontologyGSEA, gene set enrichment analysisHNSC, head and neck squamous cell carcinomaKIRC, kidney renal clear cell carcinomaKIRP, kidney renal papillary cell carcinomaLUAD, lung adenocarcinomaLUSC, lung squamous cell carcinomaOS, overall survivalOV, ovarian carcinomaPAAD, pancreatic adenocarcinomaPFI, progression-free intervalPan-cancerSARS-CoV-2, severe acute respiratory syndrome coronavirus 2SKCM, skin cutaneous melanomaSurvival prognosisTCGA, The Cancer Genome AtlasTF, transcription factorTHYM, thymomaTumor immunity and immunotherapyTumor progressionUCEC, uterine corpus endometrial carcinomaWGCNA, weighted gene co-expression network analysis
DOI
10.1016/j.csbj.2020.08.024
PMID
32905022
发布时间
2021-01-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
